Stocks and Investing
Stocks and Investing
Mon, January 28, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, January 25, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, January 24, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, January 23, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Esther Rajavelu Initiated (ALNY) at Hold on, Jan 23rd, 2019
Esther Rajavelu of UBS, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold on, Jan 23rd, 2019.
Esther has made no other calls on ALNY in the last 4 months.
There are 4 other peers that have a rating on ALNY. Out of the 4 peers that are also analyzing ALNY, 2 agree with Esther's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Paul Matteis of "Leerink Swann" Initiated at Hold and Held Target at $63 on, Wednesday, November 28th, 2018
- David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $87 on, Friday, September 28th, 2018
These are the ratings of the 2 analyists that currently disagree with Esther
- Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $124 on, Tuesday, October 16th, 2018
- Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $135 on, Monday, October 1st, 2018